Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART

Nenhuma Miniatura disponível
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
EHRENBERG, Alexander J.
KELBERMAN, Michael A.
LIU, Kathy Y.
DAHL, Martin J.
WEINSHENKER, David
FALGAS, Neus
DUTT, Shubir
MATHER, Mara
LUDWIG, Mareike
BETTS, Matthew J.
Citação
ALZHEIMERS & DEMENTIA, v.19, n.5, p.2182-2196, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The neuromodulatory subcortical system (NSS) nuclei are critical hubs for survival, hedonic tone, and homeostasis. Tau-associated NSS degeneration occurs early in Alzheimer's disease (AD) pathogenesis, long before the emergence of pathognomonic memory dysfunction and cortical lesions. Accumulating evidence supports the role of NSS dysfunction and degeneration in the behavioral and neuropsychiatric manifestations featured early in AD. Experimental studies even suggest that AD-associated NSS degeneration drives brain neuroinflammatory status and contributes to disease progression, including the exacerbation of cortical lesions. Given the important pathophysiologic and etiologic roles that involve the NSS in early AD stages, there is an urgent need to expand our understanding of the mechanisms underlying NSS vulnerability and more precisely detail the clinical progression of NSS changes in AD. Here, the NSS Professional Interest Area of the International Society to Advance Alzheimer's Research and Treatment highlights knowledge gaps about NSS within AD and provides recommendations for priorities specific to clinical research, biomarker development, modeling, and intervention. HighlightsNeuromodulatory nuclei degenerate in early Alzheimer's disease pathological stages.Alzheimer's pathophysiology is exacerbated by neuromodulatory nuclei degeneration.Neuromodulatory nuclei degeneration drives neuropsychiatric symptoms in dementia.Biomarkers of neuromodulatory integrity would be value-creating for dementia care.Neuromodulatory nuclei present strategic prospects for disease-modifying therapies.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/58043
Referências
  1. Alba-Delgado C, 2016, PROG NEURO-PSYCHOPH, V71, P45, DOI 10.1016/j.pnpbp.2016.06.007
  2. Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1
  3. Andrés-Benito P, 2017, NEUROPATH APPL NEURO, V43, P373, DOI 10.1111/nan.12386
  4. Arendt T, 2000, NEUROBIOL AGING, V21, P783, DOI 10.1016/S0197-4580(00)00216-5
  5. Arendt T, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0187-1
  6. Aroca P, 2006, J COMP NEUROL, V496, P802, DOI 10.1002/cne.20957
  7. Attems J, 2012, NEUROPATH APPL NEURO, V38, P582, DOI 10.1111/j.1365-2990.2011.01244.x
  8. Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
  9. Babiloni C, 2021, ALZHEIMERS DEMENT, V17, P1528, DOI 10.1002/alz.12311
  10. Babiloni C, 2020, NEUROBIOL AGING, V85, P58, DOI 10.1016/j.neurobiolaging.2019.09.008
  11. Bachman SL., 2022, MEDRXIV
  12. Bäckman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005
  13. Bäckman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008
  14. Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1
  15. Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451
  16. Beach TG, 2000, NEUROSCI LETT, V283, P9, DOI 10.1016/S0304-3940(00)00916-2
  17. Bekar LK, 2012, J CEREBR BLOOD F MET, V32, P2135, DOI 10.1038/jcbfm.2012.115
  18. Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44
  19. Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7
  20. Berron D, 2022, FRONT DIGIT HEALTH, V4, DOI 10.3389/fdgth.2022.892997
  21. Betts MJ, 2019, BRAIN, V142, P2558, DOI 10.1093/brain/awz193
  22. Betts MJ, 2019, ALZH DEMENT-DADM, V11, P281, DOI 10.1016/j.dadm.2019.02.001
  23. Billot B, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117287
  24. Birks J, 2006, Cochrane Database Syst Rev, pCD001190
  25. BONVENTO G, 1991, BRAIN RES REV, V16, P257, DOI 10.1016/0165-0173(91)90009-W
  26. Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
  27. Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379
  28. Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2
  29. Cassidy CM, 2022, NEUROPSYCHOPHARMACOL, V47, P1128, DOI 10.1038/s41386-022-01293-6
  30. Cazettes F, 2021, CURR BIOL, V31, P192, DOI 10.1016/j.cub.2020.09.090
  31. Chalermpalanupap T, 2018, J NEUROSCI, V38, P74, DOI 10.1523/JNEUROSCI.1483-17.2017
  32. Chamberlain SR, 2013, J PSYCHOPHARMACOL, V27, P694, DOI 10.1177/0269881113480988
  33. Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6
  34. CHARNEY DS, 1983, NEUROPHARMACOLOGY, V22, P1531, DOI 10.1016/0028-3908(83)90122-3
  35. Charney DS, 1998, NEUROSCIENTIST, V4, P35, DOI 10.1177/107385849800400111
  36. Chen YS, 2021, J ALZHEIMERS DIS, V80, P53, DOI 10.3233/JAD-201141
  37. Chen YH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019313
  38. Clewett DV, 2018, J NEUROSCI, V38, P1558, DOI 10.1523/JNEUROSCI.2097-17.2017
  39. Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013
  40. Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008
  41. Cools R, 2022, NEUROPSYCHOPHARMACOL, V47, P309, DOI 10.1038/s41386-021-01100-8
  42. Counts SE, 2010, J NEUROCHEM, V113, P649, DOI 10.1111/j.1471-4159.2010.06622.x
  43. Cummings J, 2022, ALZH DEMENT-TRCI, V8, DOI 10.1002/trc2.12295
  44. CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308
  45. CURCIO CA, 1984, J NEUROPATH EXP NEUR, V43, P359, DOI 10.1097/00005072-198407000-00001
  46. Dahl MJ, 2022, NEUROBIOL AGING, V112, P39, DOI 10.1016/j.neurobiolaging.2021.11.006
  47. Dahl MJ, 2022, TRENDS COGN SCI, V26, P38, DOI 10.1016/j.tics.2021.10.009
  48. Dahl MJ, 2019, NAT HUM BEHAV, V3, P1203, DOI 10.1038/s41562-019-0715-2
  49. Davis JJ, 2021, J GERIATR PSYCH NEUR, V34, P3, DOI 10.1177/0891988720901785
  50. Defrancesco M, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv055
  51. Doppler CEJ, 2021, BRAIN, V144, P2732, DOI 10.1093/brain/awab236
  52. Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7
  53. Eck SR, 2020, BIOL PSYCHIAT, V88, P566, DOI 10.1016/j.biopsych.2020.04.013
  54. Ehrenberg AJ, 2017, NEUROPATH APPL NEURO, V43, P393, DOI 10.1111/nan.12387
  55. Ehrenberg AJ, 2018, J ALZHEIMERS DIS, V66, P115, DOI 10.3233/JAD-180688
  56. Elman JA, 2021, ALZHEIMERS DEMENT, V17, P1017, DOI 10.1002/alz.12261
  57. España RA, 2016, BRAIN RES, V1641, P207, DOI 10.1016/j.brainres.2016.01.002
  58. ESTRADA C, 1983, BRAIN RES, V266, P261, DOI 10.1016/0006-8993(83)90657-1
  59. Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649
  60. FELTEN DL, 1979, AM J ANAT, V155, P467, DOI 10.1002/aja.1001550405
  61. Feng CY, 2011, J NEUROSCI, V31, P9147, DOI 10.1523/JNEUROSCI.5018-10.2011
  62. Figlewicz DP, 1996, BRAIN RES, V736, P54, DOI 10.1016/S0006-8993(96)00727-5
  63. Finley KH, 1939, J COMP NEUROL, V71, P1, DOI 10.1002/cne.900710102
  64. Finley KH, 1940, J COMP NEUROL, V73, P49, DOI 10.1002/cne.900730105
  65. Finley KH, 1936, ARCH NEURO PSYCHIATR, V36, P118, DOI 10.1001/archneurpsyc.1936.02260070126010
  66. Fritz HCJ, 2019, HUM BRAIN MAPP, V40, P868, DOI 10.1002/hbm.24417
  67. George SA, 2013, EUR J NEUROSCI, V37, P901, DOI 10.1111/ejn.12095
  68. Ghosh A, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0511-2
  69. Giorgi FS, 2020, J NEUROSCI RES, V98, P2406, DOI 10.1002/jnr.24718
  70. Greve DN, 2021, NEUROIMAGE, V244, DOI 10.1016/j.neuroimage.2021.118610
  71. Grinberg Lea Tenenholz, 2007, Dement. neuropsychol., V1, P140, DOI 10.1590/s1980-57642008dn10200005
  72. Grinberg LT, 2010, J NEUROL SCI, V289, P81, DOI 10.1016/j.jns.2009.08.021
  73. Grueschow M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22509-1
  74. HARIK SI, 1986, P NATL ACAD SCI USA, V83, P4067, DOI 10.1073/pnas.83.11.4067
  75. HARTMAN BK, 1972, P NATL ACAD SCI USA, V69, P2722, DOI 10.1073/pnas.69.9.2722
  76. Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107
  77. Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006
  78. Herring WJ, 2020, ALZHEIMERS DEMENT, V16, P541, DOI 10.1002/alz.12035
  79. HORSTMANN E, 1954, Z ZELLFORSCH MIK ANA, V39, P588, DOI 10.1007/BF00334758
  80. Il Jacobs H, 2020, ELIFE, V9, DOI 10.7554/eLife.52059
  81. Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934
  82. Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018
  83. Jacobs HIL, 2023, ALZHEIMERS DEMENT, V19, P169, DOI 10.1002/alz.12656
  84. Jacobs HIL, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abj2511
  85. Jacobs HIL, 2021, MOL PSYCHIATR, V26, P897, DOI 10.1038/s41380-019-0437-x
  86. Jacobs HIL, 2015, NEUROBIOL AGING, V36, P1860, DOI 10.1016/j.neurobiolaging.2015.02.023
  87. Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7
  88. Jardanhazi-Kurutz D, 2010, NEUROCHEM INT, V57, P375, DOI 10.1016/j.neuint.2010.02.001
  89. Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001
  90. Jones HE, 2016, AGE AGEING, V45, P448, DOI 10.1093/ageing/afw053
  91. Joshi S, 2020, TRENDS COGN SCI, V24, P466, DOI 10.1016/j.tics.2020.03.005
  92. Kalinin S, 2007, NEUROBIOL AGING, V28, P1206, DOI 10.1016/j.neurobiolaging.2006.06.003
  93. Kang SS, 2020, J CLIN INVEST, V130, P422, DOI 10.1172/JCI130513
  94. Kang YN, 2019, ANIM CELLS SYST, V23, P275, DOI 10.1080/19768354.2019.1626280
  95. Kelly L, 2021, NEUROPATH APPL NEURO, V47, P488, DOI 10.1111/nan.12674
  96. Kelly SC, 2019, J ALZHEIMERS DIS, V70, P369, DOI 10.3233/JAD-190090
  97. Keute M, 2021, CORTEX, V140, P222, DOI 10.1016/j.cortex.2021.04.004
  98. Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3
  99. Kjaerby C, 2022, NAT NEUROSCI, V25, P1059, DOI 10.1038/s41593-022-01102-9
  100. Klimek V, 1997, J NEUROSCI, V17, P8451
  101. Ko Y, 2020, REV NEUROSCIENCE, V31, P817, DOI 10.1515/revneuro-2020-0072
  102. Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2
  103. Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099
  104. Krystal JH, 2018, BIOL PSYCHIAT, V83, P197, DOI 10.1016/j.biopsych.2017.09.027
  105. Lee DA, 2020, ELIFE, V9, DOI 10.7554/eLife.54491
  106. Lee JY, 2022, NAT REV NEUROL, V18, P203, DOI 10.1038/s41582-022-00618-9
  107. Leung DKY, 2021, INT J GERIATR PSYCH, V36, P1330, DOI 10.1002/gps.5556
  108. Levey AI, 2022, BRAIN, V145, P1924, DOI 10.1093/brain/awab452
  109. Lew CH, 2021, SLEEP MED REV, V60, DOI 10.1016/j.smrv.2021.101541
  110. Li SL, 2019, CELL REP, V28, P682, DOI 10.1016/j.celrep.2019.06.042
  111. Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1
  112. Liguori C, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-019-0571-3
  113. Liguori C, 2014, JAMA NEUROL, V71, P1498, DOI 10.1001/jamaneurol.2014.2510
  114. Liu AKL, 2015, ACTA NEUROPATHOL, V129, P527, DOI 10.1007/s00401-015-1392-5
  115. Liu KP, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-15410-w, 10.1038/s41467-020-14984-9]
  116. Liu KY, 2018, AGEING RES REV, V43, P99, DOI 10.1016/j.arr.2018.03.003
  117. Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
  118. Luckey AM, 2020, NEUROREHAB NEURAL RE, V34, P1020, DOI 10.1177/1545968320943573
  119. Ludwig M, 2021, AUTON NEUROSCI-BASIC, V236, DOI 10.1016/j.autneu.2021.102900
  120. Lüdtke S, 2021, CLIN NEUROPHYSIOL, V132, P137, DOI 10.1016/j.clinph.2020.10.019
  121. Lynch CJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108540
  122. Lyness SA, 2003, NEUROBIOL AGING, V24, P1, DOI 10.1016/S0197-4580(02)00057-X
  123. MA PM, 1994, J COMP NEUROL, V344, P256, DOI 10.1002/cne.903440207
  124. Mahabadi VP, 2015, INT J MOL CELL MED, V4, P22
  125. MANN DMA, 1980, BRIT J PSYCHIAT, V136, P533, DOI 10.1192/bjp.136.6.533
  126. Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010
  127. Mather M, 2017, NEUROIMAGE, V150, P329, DOI 10.1016/j.neuroimage.2017.02.025
  128. Mather M, 2016, TRENDS COGN SCI, V20, P214, DOI 10.1016/j.tics.2016.01.001
  129. Mather M, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X15000667
  130. Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886
  131. Mertens A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00551
  132. MESULAM MM, 1988, J COMP NEUROL, V275, P216, DOI 10.1002/cne.902750205
  133. Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5
  134. Mileticic S, 2020, NEUROIMAGE, V219, DOI 10.1016/j.neuroimage.2020.116992
  135. Mir FA, 2021, NEUROSCI BULL, V37, P684, DOI 10.1007/s12264-020-00625-0
  136. Monti JM, 2015, PROG NEURO-PSYCHOPH, V56, P185, DOI 10.1016/j.pnpbp.2014.09.003
  137. Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
  138. MUFSON EJ, 1988, ANN NEUROL, V24, P623, DOI 10.1002/ana.410240506
  139. Munn B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26268-x
  140. Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466
  141. Nizari S, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01108-z
  142. Nyberg L, 2016, P NATL ACAD SCI USA, V113, P7918, DOI 10.1073/pnas.1606309113
  143. Oh J, 2019, ALZHEIMERS DEMENT, V15, P1253, DOI 10.1016/j.jalz.2019.06.3916
  144. OHM TG, 1989, NEUROSCI LETT, V96, P60, DOI 10.1016/0304-3940(89)90243-7
  145. Okaty BW, 2019, NAT REV NEUROSCI, V20, P397, DOI 10.1038/s41583-019-0151-3
  146. Parvizi J, 2001, ANN NEUROL, V49, P53, DOI 10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q
  147. Plummer NW, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00060
  148. Pomrenze MB, 2021, NEUROPHARMACOLOGY, V198, DOI 10.1016/j.neuropharm.2021.108769
  149. Priovoulos N, 2018, NEUROIMAGE, V168, P427, DOI 10.1016/j.neuroimage.2017.07.045
  150. Puckett AM, 2018, NEUROIMAGE, V172, P886, DOI 10.1016/j.neuroimage.2017.12.005
  151. Ravichandran S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83116-0
  152. Reimer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13289
  153. Rey NL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.026
  154. Ricci L, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100668
  155. Risk BB, 2021, NEUROIMAGE, V245, DOI 10.1016/j.neuroimage.2021.118646
  156. ROBBINS TW, 1987, NEUROPHARMACOLOGY, V26, P893, DOI 10.1016/0028-3908(87)90067-0
  157. Rodríguez E, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12690
  158. Rohm B, 2013, MOL NUTR FOOD RES, V57, P2008, DOI 10.1002/mnfr.201200846
  159. Rorabaugh JM, 2017, BRAIN, V140, P3023, DOI 10.1093/brain/awx232
  160. Rosenberg A, 2020, JPAD-J PREV ALZHEIM, V7, P29, DOI 10.14283/jpad.2019.41
  161. Rosenberg PB, 2015, MOL ASPECTS MED, V43-44, P25, DOI 10.1016/j.mam.2015.05.005
  162. Rüb U, 2016, CURR ALZHEIMER RES, V13, P1178, DOI 10.2174/1567205013666160606100509
  163. Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573
  164. Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014
  165. Schmitz TW, 2020, J NEUROSCI, V40, P1931, DOI 10.1523/JNEUROSCI.1184-19.2019
  166. Schwarz LA, 2015, CURR BIOL, V25, pR1051, DOI 10.1016/j.cub.2015.09.039
  167. Scinto LFM, 1999, ACTA NEUROPATHOL, V97, P557, DOI 10.1007/s004010051031
  168. Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006
  169. Stratmann K, 2016, BRAIN PATHOL, V26, P371, DOI 10.1111/bpa.12289
  170. Strauch C, 2022, TRENDS NEUROSCI, V45, P635, DOI 10.1016/j.tins.2022.05.003
  171. Sulzer D, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0047-3
  172. Swift KM, 2018, CURR BIOL, V28, P3599, DOI 10.1016/j.cub.2018.09.054
  173. Theofilas P, 2017, ALZHEIMERS DEMENT, V13, P236, DOI 10.1016/j.jalz.2016.06.2362
  174. Thiele A, 2018, NEURON, V97, P769, DOI 10.1016/j.neuron.2018.01.008
  175. Tiepolt S, 2022, J NUCL MED, V63, p33S, DOI 10.2967/jnumed.121.263198
  176. Toljan Karlo, 2021, Handb Clin Neurol, V179, P285, DOI 10.1016/B978-0-12-819975-6.00018-2
  177. Vadodaria KC, 2016, BIOESSAYS, V38, P1123, DOI 10.1002/bies.201600127
  178. Van Egroo M, 2022, SLEEP MED REV, V62, DOI 10.1016/j.smrv.2022.101592
  179. Van Egroo M, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-021-00902-8
  180. Van Egroo M, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz017
  181. Wang CN, 2020, NEUROPSYCHOPHARMACOL, V45, P104, DOI 10.1038/s41386-019-0478-5
  182. Wang S., 2022, BRAIN SCI, P12
  183. Watson C, 2017, J COMP NEUROL, V525, P2782, DOI 10.1002/cne.24242
  184. Weinshenker D, 2018, TRENDS NEUROSCI, V41, P211, DOI 10.1016/j.tins.2018.01.010
  185. WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341
  186. WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203
  187. Wingstrand KG., 1951, THESIS LUND
  188. Wucherer D, 2017, INT PSYCHOGERIATR, V29, P1857, DOI 10.1017/S1041610217001442
  189. YAMAMOTO T, 1985, ANN NEUROL, V17, P573, DOI 10.1002/ana.410170608
  190. Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010
  191. ZWEIG RM, 1988, ANN NEUROL, V24, P233, DOI 10.1002/ana.410240210

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - LIM/22